Correlation Between OncoCyte Corp and Trinity Biotech

Can any of the company-specific risk be diversified away by investing in both OncoCyte Corp and Trinity Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoCyte Corp and Trinity Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between OncoCyte Corp and Trinity Biotech plc, you can compare the effects of market volatilities on OncoCyte Corp and Trinity Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoCyte Corp with a short position of Trinity Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoCyte Corp and Trinity Biotech.

Diversification Opportunities for OncoCyte Corp and Trinity Biotech

0.6

Correlation Coefficient

OncoCyte Corp  Trinity Biotech

Poor diversification

The 3 months correlation between OncoCyte and Trinity is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding OncoCyte Corp and Trinity Biotech plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trinity Biotech plc and OncoCyte Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoCyte Corp are associated (or correlated) with Trinity Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trinity Biotech plc has no effect on the direction of OncoCyte Corp i.e., OncoCyte Corp and Trinity Biotech go up and down completely randomly.

Pair Corralation between OncoCyte Corp and Trinity Biotech

Considering the 90-day investment horizon OncoCyte Corp is expected to generate 0.5 times more return on investment than Trinity Biotech. However, OncoCyte Corp is 1.99 times less risky than Trinity Biotech. It trades about -0.11 of its potential returns per unit of risk. Trinity Biotech plc is currently generating about -0.09 per unit of risk. If you would invest  305.00  in OncoCyte Corp on September 5, 2024 and sell it today you would lose (65.00) from holding OncoCyte Corp or give up 21.31% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

OncoCyte Corp  vs.  Trinity Biotech plc

OncoCyte Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days OncoCyte Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Trinity Biotech plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Trinity Biotech plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with OncoCyte Corp and Trinity Biotech

The main advantage of trading using opposite OncoCyte Corp and Trinity Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoCyte Corp position performs unexpectedly, Trinity Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trinity Biotech will offset losses from the drop in Trinity Biotech's long position.

The idea behind OncoCyte Corp and Trinity Biotech plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.